BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16608246)

  • 1. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
    Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
    J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of C-glycoside flavonoids as potential mutagenic compounds in kava.
    Jhoo JW; Ang CY; Heinze TM; Deck J; Schnackenberg LK; Beger RD; Dragull K; Tang CS
    J Food Sci; 2007 Mar; 72(2):C120-5. PubMed ID: 17995826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
    Nerurkar PV; Dragull K; Tang CS
    Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the alkaloid pipermethystine connected with the claimed liver toxicity of Kava products?
    Lechtenberg M; Quandt B; Schmidt M; Nahrstedt A
    Pharmazie; 2008 Jan; 63(1):71-4. PubMed ID: 18271308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous kava extracts do not affect liver function tests in rats.
    Singh YN; Devkota AK
    Planta Med; 2003 Jun; 69(6):496-9. PubMed ID: 12865965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
    Petersen GE; Tang Y; Fields C
    J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Purification of Potent Growth Inhibitors from
    Van TM; Xuan TD; Minh TN; Quan NV
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular toxicity of kava leaf and root extracts.
    Lüde S; Török M; Dieterle S; Jäggi R; Büter KB; Krähenbühl S
    Phytomedicine; 2008 Jan; 15(1-2):120-31. PubMed ID: 18055189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperidine alkaloids from Piper methysticum.
    Dragull K; Yoshida WY; Tang CS
    Phytochemistry; 2003 May; 63(2):193-8. PubMed ID: 12711141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.
    Teschke R; Qiu SX; Lebot V
    Dig Liver Dis; 2011 Sep; 43(9):676-81. PubMed ID: 21377431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.
    Xuan TD; Fukuta M; Wei AC; Elzaawely AA; Khanh TD; Tawata S
    J Nat Med; 2008 Apr; 62(2):188-94. PubMed ID: 18404321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
    Tugcu G; Kırmızıbekmez H; Aydın A
    Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Densitometric analysis of kawain in kava-kava root extracts.
    Janeczko Z; Krzek J; Pilewski N; Walusiak D
    Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are mould hepatotoxins responsible for kava hepatotoxicity?
    Rowe A; Ramzan I
    Phytother Res; 2012 Nov; 26(11):1768-70. PubMed ID: 22319018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.